In adults, AXL expression is relatively low (Vajkoczy et al., 2006), but aberrant Gas6/AXL expression has been detected in a number of human malignancies, including breast cancer, chronic lymphocytic leukemia (CLL), lung cancer, pancreatic cancer, glioblastoma, melanoma. This evidence concerns the gene GAS6 and B-cell chronic lymphocytic leukemia.